文献速递颈动脉与弓上血管

采用直接颈动脉支架置入技术不影响围手术期结局

Use of a primary carotid stenting technique does not affect perioperative outcomes.
PubMed 文献 · J Vasc Surg · 2018-02-02

基于血管质量倡议(VQI)数据库2005—2016年10074例颈动脉支架置入(CAS)患者,比较直接颈动脉支架置入(PCS+)与常规球囊血管成形后支架(PCS-)的30天卒中/死亡复合终点。单因素分析PCS+高于PCS-(5.2% vs 3.4%,P=0.01),校正基线差异后无统计学显著差异(OR 1.15,95%CI 0.72-1.83,P=0.55);未使用栓塞保护装置者卒中/死亡风险显著升高(OR 3.97,95%CI 2.47-6.37)。

要点

  • 校正基线差异后,PCS+与PCS-的30天卒中/死亡复合终点无统计学显著差异(OR 1.15,95%CI 0.72-1.83)。
  • 按症状状态分层及使用栓塞保护装置患者中,PCS对复合终点均无显著影响。
  • 无论采用何种支架技术,未使用栓塞保护装置者卒中/死亡风险显著升高(OR 3.97,95%CI 2.47-6.37)。

核心结论

  • PCS与常规球囊血管成形后CAS相比,卒中与死亡风险相似。
  • 使用栓塞保护装置对两种技术获得良好结局均至关重要。

研究设计与样本

  • 基于VQI数据库2005—2016年全部CAS病例的多中心队列分析,共纳入10074例患者(平均年龄69.5±9.9岁,64%为男性)。
  • 采用单因素和多因素logistic回归评估PCS对结局的影响,主要终点为30天内卒中/死亡复合终点。

主要发现

  • 复合终点总发生率为3.5%(卒中2.4%,死亡1.5%)。
  • PCS用于688例(6.8%)患者。
  • 单因素分析中PCS+的卒中/死亡发生率高于PCS-(5.2% vs 3.4%,P=0.01)。
  • 校正基线组间差异后差异不再显著(OR 1.15,95%CI 0.72-1.83,P=0.55)。
  • 按症状状态分层:无症状者OR 0.98(95%CI 0.39-2.48),有症状者OR 1.19(95%CI 0.66-2.06);使用栓塞保护装置者OR 1.54(95%CI 0.92-2.57)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary carotid stenting (PCS) has been shown to be feasible and safe in small series, but real-world outcomes in a large multicenter data set have yet to be explored. We aimed to compare outcomes for PCS (PCS+) vs conventional carotid artery stenting (CAS) with angioplasty (PCS-) using a national database. METHODS: We analyzed all CAS cases in the Vascular Quality Initiative (VQI) database (2005-2016) using univariable and multivariable logistic regression to assess the effect of PCS on outcomes. The primary end point was a composite of stroke/death occurring within 30 days. RESULTS: The study included 10,074 patients (mean age, 69.5 ± 9.9 years; 64% male). The composite end point occurred in 3.5% of cases (stroke, 2.4%; death, 1.5%). PCS was used in 688 (6.8%) patients. On univariable analysis, stroke/death occurred more frequently with PCS+ vs PCS- (5.2% vs 3.4%; P = .01). However, this difference was mitigated after adjusting for baseline group differences (odds ratio [OR], 1.15; 95% confidence interval [CI], 0.72-1.83; P = .55). PCS also had no significant effect on the primary composite end point on adjusted analysis stratified by symptom status (asymptomatic: OR, 0.98 [95% CI, 0.39-2.48]; symptomatic: OR, 1.19 [95% CI 0.66-2.06]) or among patients undergoing CAS with embolic protection (OR, 1.54 [95% CI, 0.92-2.57]). Patients undergoing CAS without embolic protection had a significantly higher risk of stroke/death regardless of the stenting technique used (OR, 3.97 [95% CI, 2.47-6.37]). CONCLUSIONS: PCS is associated with a similar risk of stroke and death compared with conventional CAS with angioplasty. The use of an embolic protection device is essential to good outcomes with both techniques.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hicks CW, Nejim B, Obeid T, et al. Use of a primary carotid stenting technique does not affect perioperative outcomes. J Vasc Surg. 2018. PMID: 29398315. doi:10.1016/j.jvs.2017.09.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。